Literature DB >> 17239628

Seizure freedom off antiepileptic drugs after temporal lobe epilepsy surgery.

Muhammad Al-Kaylani1, Peter Konrad, Barry Lazenby, Bennett Blumenkopf, Bassel Abou-Khalil.   

Abstract

Data are limited on seizure recurrence after antiepileptic drug (AED) discontinuation in operated seizure-free patients. We reviewed seizure outcome in patients who came off AEDs after being seizure-free for 2 years following temporal lobe surgery in our center. Thirty-nine (68%) of 57 patients who discontinued AED therapy remained seizure-free. They had a younger age at surgery than the group with seizure recurrence (p=0.01). Earlier surgery may be a favorable predictor for seizure freedom after AED discontinuation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17239628     DOI: 10.1016/j.seizure.2006.10.007

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  5 in total

1.  Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections?

Authors:  Barbara Schmeiser; Bernhard J Steinhoff; Andreas Schulze-Bonhage
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

Review 2.  Treatment of epileptic seizures in brain tumors: a critical review.

Authors:  R Bauer; M Ortler; M Seiz-Rosenhagen; R Maier; J V Anton; I Unterberger
Journal:  Neurosurg Rev       Date:  2014-04-24       Impact factor: 3.042

3.  Antiepileptic medications after extratemporal epilepsy surgery: when do we stop?

Authors:  Mohamad Koubeissi
Journal:  Epilepsy Curr       Date:  2013-01       Impact factor: 7.500

Review 4.  Brain stimulation treatments in epilepsy: Basic mechanisms and clinical advances.

Authors:  Thomas J Foutz; Michael Wong
Journal:  Biomed J       Date:  2021-09-02       Impact factor: 7.892

5.  The role of brain magnetic resonance imaging on the timing of antiepileptic drugs withdrawal following mesial temporal lobe epilepsy surgery.

Authors:  Miad Albalawi; Fawzi Babtain; Saleh Baeesa; Youssef Al-Said; Khalid Alqadi
Journal:  Neurosciences (Riyadh)       Date:  2021-07       Impact factor: 0.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.